Across the Nutraverse: B6 in Australia, McKinsey’s wellness report, CreaBoost in the USA
2 Articles
2 Articles
This week's Nutraverse: B6 in Australia, McKinsey’s wellness report, CreaBoost in the USA - Dining and Cooking
Australia’s Therapeutic Goods Administration is consulting on stronger labeling requirements for listed medicines containing vitamin B6. The concern is that excessive or cumulative intake can increase the risk of peripheral neuropathy, which may result in severe, debilitating and potentially long-term nerve damage. Currently, vitamin B6 products providing more than 10 mg equivalent pyridoxine per day [...]
Across the Nutraverse: B6 in Australia, McKinsey’s wellness report, CreaBoost in the USA
Australia’s Therapeutic Goods Administration is proposing stricter labeling and classification for vitamin B6 supplements due to risks of nerve damage from excessive intake, urging manufacturers to review cumulative exposure across product portfolios. In the US, Vireo Systems is investing over $20 million to produce premium creatine monohydrate domestically, promising improved quality, supply chain control, and regional competitiveness. Meanwhil…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium



